
Forbes @Forbes
Battered by a steep broad-market selloff this week, Moderna shares fell for a sixth straight day Friday as experts questioned whether Covid-19 vaccine sales alone will help justify the firm’s meteoric valuation. https://t.co/GGSWnlCxFe — PolitiTweet.org